Literature DB >> 2470925

Nonoperative management of benign prostatic hyperplasia.

H Lepor1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470925     DOI: 10.1016/s0022-5347(17)41282-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  18 in total

1.  Role of Primary Care Clinicians in the Diagnosis and Treatment of LUTS and BPH.

Authors:  Louis Kuritzky
Journal:  Rev Urol       Date:  2004

2.  Transurethral laser ablation of the prostate--long-term results.

Authors:  A J Costello; D G Lusaya; H R Crowe
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

3.  Medical treatment of benign prostatic hyperplasia.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2011

Review 4.  Obstruction-induced alterations within the urinary bladder and their role in the pathophysiology of lower urinary tract symptomatology.

Authors:  Christos Komninos; Iraklis Mitsogiannis
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

5.  The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2006

Review 6.  Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia.

Authors:  Youngjoo Kwon
Journal:  Food Sci Biotechnol       Date:  2019-04-17       Impact factor: 2.391

Review 7.  Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; E M Sorkin
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 8.  Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; D McTavish
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 9.  Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia.

Authors:  D H Peters; E M Sorkin
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

10.  Alpha blockers for the treatment of benign prostatic hyperplasia.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.